• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童期使用抗生素作为克罗恩病的一个风险因素:ENIGMA国际队列研究

Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study.

作者信息

Mak Joyce W Y, Yang Sun, Stanley Annalise, Lin Xiaoqing, Morrison Mark, Ching Jessica Y L, Niu Junkun, Wilson-O'Brien Amy L, Feng Rui, Tang Whitney, Hamilton Amy L, Or Leo, Trakman Gina L, Lin Winnie Y Y, Sung Joseph J Y, Chen Ming Hu, Mao Yinglei, Kamm Michael A, Ng Siew C

机构信息

Department of Medicine and Therapeutics, Institute of Digestive Disease The Chinese University of Hong Kong Shatin Hong Kong.

Department of Gastroenterology First Affiliated Hospital of Kunming Medical University Kunming Yunnan China.

出版信息

JGH Open. 2022 Jun 1;6(6):369-377. doi: 10.1002/jgh3.12755. eCollection 2022 Jun.

DOI:10.1002/jgh3.12755
PMID:35774350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9218523/
Abstract

BACKGROUND AND AIM

Environmental factors play a key role in development of Crohn's disease (CD), thought to be mediated by changes in the gut microbiota. We aimed to delineate the potential contribution of antibiotic exposure to subsequent development of CD, across diverse geographical populations.

METHODS

This case-control study in Australia and three cities in China (Hong Kong, Guangzhou, and Kunming) included four groups: patients with CD, at-risk individuals including non-affected first-degree relatives (FDRs) and household members of CD patients (HM), and unrelated healthy controls (HCs). Environmental risk factors, including childhood antibiotic use and 13 other categories, were assessed using a self-developed questionnaire. Logistic regression and conditional logistic regression were used to determine environmental factors associated with CD development.

RESULTS

From 2017 to 2019, a total of 254 patients with CD (mean age: 37.98 ± 13.76 years; 58.3% male), 73 FDR (mean age: 49.35 ± 13.28 years; 46.6% male), 122 HMs (including FDR) (mean age: 45.50 ± 13.25 years; 47.5% male), and 78 HC (mean age: 45.57 ± 11.24; 47.4% male) were included. Comparing CD patients with their FDR and HMs, antibiotic use before 18 years old was a risk factor for CD development (adjusted odds ratio [OR] 3.46, 95% confidence interval [CI] 1.38-8.69;  = 0.008). There were no significant differences in other childhood environmental risk factors between CD and their FDR or HMs. Subgroup analysis showed that antibiotic use <18 years old was a risk factor for CD development in the Chinese (adjusted OR 4.80, 95% CI 1.62-12.24;  = 0.005) but not in Australian populations (OR 1.80, 95% CI 0.33-9.95;  = 0.498).

CONCLUSION

Use of antibiotics <18 years was a risk factor for CD development. Attention should be paid to identifying modifiable environmental risk factors in early childhood, especially in at-risk families.

摘要

背景与目的

环境因素在克罗恩病(CD)的发生发展中起关键作用,一般认为是通过肠道微生物群的变化介导的。我们旨在明确在不同地理区域人群中,抗生素暴露对CD后续发病的潜在影响。

方法

这项在澳大利亚以及中国三个城市(香港、广州和昆明)开展的病例对照研究包括四组:CD患者、高危个体,包括未患病的一级亲属(FDR)和CD患者的家庭成员(HM),以及无关健康对照(HC)。使用自行编制的问卷评估环境危险因素,包括儿童期抗生素使用情况以及其他13类因素。采用逻辑回归和条件逻辑回归确定与CD发病相关的环境因素。

结果

2017年至2019年,共纳入254例CD患者(平均年龄:37.98±13.76岁;男性占58.3%)、73名FDR(平均年龄:49.35±13.28岁;男性占46.6%)、122名HM(包括FDR)(平均年龄:45.50±13.25岁;男性占47.5%)和78名HC(平均年龄:45.57±11.24岁;男性占47.4%)。将CD患者与其FDR和HM进行比较,18岁之前使用抗生素是CD发病的危险因素(调整比值比[OR] 3.46,95%置信区间[CI] 1.38 - 8.69;P = 0.008)。CD患者与其FDR或HM在其他儿童期环境危险因素方面无显著差异。亚组分析显示,18岁之前使用抗生素是中国人群中CD发病的危险因素(调整OR 4.80,95% CI 1.62 - 12.24;P = 0.005),但在澳大利亚人群中并非如此(OR 1.80,95% CI 0.33 - 9.95;P = 0.498)。

结论

18岁之前使用抗生素是CD发病的危险因素。应重视识别儿童早期尤其是高危家庭中可改变的环境危险因素。

相似文献

1
Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study.儿童期使用抗生素作为克罗恩病的一个风险因素:ENIGMA国际队列研究
JGH Open. 2022 Jun 1;6(6):369-377. doi: 10.1002/jgh3.12755. eCollection 2022 Jun.
2
Processed Food as a Risk Factor for the Development and Perpetuation of Crohn's Disease-The ENIGMA Study.加工食品是克罗恩病发展和持续存在的危险因素——ENIGMA 研究。
Nutrients. 2022 Sep 2;14(17):3627. doi: 10.3390/nu14173627.
3
IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn's Disease Patients.克罗恩病患者健康一级亲属的炎症性肠病遗传风险概况
J Crohns Colitis. 2016 Feb;10(2):209-15. doi: 10.1093/ecco-jcc/jjv197. Epub 2015 Oct 28.
4
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's Disease.来自复杂家系的健康一级亲属与简单家系的健康一级亲属相比,具有更高的亚临床肠道炎症、独特的粪便微生物特征,并且患克罗恩病的风险更高。
Gastroenterology. 2025 Jan;168(1):99-110.e2. doi: 10.1053/j.gastro.2024.08.031. Epub 2024 Sep 3.
5
Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.抗微生物抗体反应与克罗恩病的未来发病相关,而与改变肠道屏障功能、亚临床炎症和遗传风险的生物标志物无关。
Gastroenterology. 2021 Nov;161(5):1540-1551. doi: 10.1053/j.gastro.2021.07.009. Epub 2021 Jul 20.
6
The Gut Microbial Profile of Preclinical Crohn's Disease Is Similar to That of Healthy Controls.临床前克罗恩病的肠道微生物特征与健康对照相似。
Inflamm Bowel Dis. 2020 Oct 23;26(11):1682-1690. doi: 10.1093/ibd/izaa072.
7
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
8
The association between childhood environmental exposures and the subsequent development of Crohn's disease in the Western Cape, South Africa.南非西开普省儿童环境暴露与随后克罗恩病发病之间的关联。
PLoS One. 2014 Dec 16;9(12):e115492. doi: 10.1371/journal.pone.0115492. eCollection 2014.
9
Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink.儿童和青少年时期使用抗生素与炎症性肠病风险的关系:英国临床实践研究数据库中的病例对照研究。
Inflamm Bowel Dis. 2020 Feb 11;26(3):440-447. doi: 10.1093/ibd/izz137.
10
Antibiotics for induction and maintenance of remission in Crohn's disease.用于诱导和维持克罗恩病缓解的抗生素。
Cochrane Database Syst Rev. 2019 Feb 7;2(2):CD012730. doi: 10.1002/14651858.CD012730.pub2.

引用本文的文献

1
Inflammatory bowel disease: a narrative review of disease evolution in South Asia and India over the last decade.炎症性肠病:过去十年南亚和印度疾病演变的叙述性综述
Therap Adv Gastroenterol. 2024 Nov 20;17:17562848241258360. doi: 10.1177/17562848241258360. eCollection 2024.
2
Helminth Lessons in Inflammatory Bowel Diseases (IBD).炎症性肠病(IBD)中的蠕虫学课程
Biomedicines. 2023 Apr 18;11(4):1200. doi: 10.3390/biomedicines11041200.
3
Does the road to primary prevention of inflammatory bowel disease start from childhood?

本文引用的文献

1
The epidemiology of inflammatory bowel disease: East meets west.炎症性肠病的流行病学:东方与西方的交汇
J Gastroenterol Hepatol. 2020 Mar;35(3):380-389. doi: 10.1111/jgh.14872. Epub 2019 Nov 24.
2
Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.环境风险因素与炎症性肠病:荟萃分析的伞式综述。
Gastroenterology. 2019 Sep;157(3):647-659.e4. doi: 10.1053/j.gastro.2019.04.016. Epub 2019 Apr 20.
3
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
炎症性肠病的一级预防之路始于童年吗?
JGH Open. 2022 Jun 22;6(6):365-368. doi: 10.1002/jgh3.12782. eCollection 2022 Jun.
21 世纪全球炎症性肠病的发病率和流行率:基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
4
Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis.溃疡性结肠炎患者炎症性肠病的家族聚集性。
Intest Res. 2017 Jul;15(3):388-394. doi: 10.5217/ir.2017.15.3.388. Epub 2017 Jun 12.
5
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.全基因组关联研究表明多种整合素基因的免疫激活与炎症性肠病有关。
Nat Genet. 2017 Feb;49(2):256-261. doi: 10.1038/ng.3760. Epub 2017 Jan 9.
6
Ulcerative colitis.溃疡性结肠炎。
Lancet. 2017 Apr 29;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2. Epub 2016 Dec 1.
7
Crohn's disease.克罗恩病。
Lancet. 2017 Apr 29;389(10080):1741-1755. doi: 10.1016/S0140-6736(16)31711-1. Epub 2016 Dec 1.
8
Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.1981年至2014年炎症性肠病的流行病学:香港全地区基于人群的登记研究结果
Inflamm Bowel Dis. 2016 Aug;22(8):1954-60. doi: 10.1097/MIB.0000000000000846.
9
Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities.炎症性肠病的临床前疾病与预防策略:观点、挑战与机遇
Gut. 2016 Jul;65(7):1061-9. doi: 10.1136/gutjnl-2016-311785. Epub 2016 May 3.
10
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.关联分析确定了38个炎症性肠病的易感基因座,并突出了不同人群间共有的遗传风险。
Nat Genet. 2015 Sep;47(9):979-986. doi: 10.1038/ng.3359. Epub 2015 Jul 20.